Anti-GL50 antibodies

Details Anti-GL50 antibodies Anti-GL50 antibodies

2005-12-19

2009-10-13

Ouspenski, Ilia (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

Reexamination Certificate

active

07601813

ABSTRACT:
The invention provides isolated nucleic acids molecules, designated GL50 nucleic acid molecules, which encode novel GL50 polypeptides. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing GL50 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a GL50 gene has been introduced or disrupted. The invention still further provides isolated GL50 polypeptides, fusion proteins, antigenic peptides and anti-GL50 antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.

REFERENCES:
patent: 4837306 (1989-06-01), Ling et al.
patent: 5580756 (1996-12-01), Linsley et al.
patent: 6130316 (2000-10-01), Freeman et al.
patent: 984 023 (2000-03-01), None
patent: WO 98/38216 (1998-09-01), None
patent: WO 99/15553 (1999-04-01), None
patent: WO 00/46240 (2000-08-01), None
GenBank Accession No. NM—005191, version of Aug. 31, 2006.
GenBank Accession No. NM—015259, version of Jan. 29, 2005.
Aicher et al., “Characterization of human inducible costimulator ligand expression and function,” J. Immunol., 164(9):4689-96 (2000).
Attwood, T., “The Babel of Bioinformatics,” Science, 290:471-473 (2000).
Benjafield et al., “G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension,” Hypertension, 32(6):1094-7 (1998).
Brodie et al., “LICOS, a primordial costimulatory ligand?,” Curr. Biol., 10(6):333-336 (2000).
Butz et al., “A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain,” Cell 94(6):773-782 (1998).
Database EMBL Acc. No. AB014553 forHomo sapiensmRNA for KIAA0653 protein, partial cds Jul. 15, 1998.
Database EMBL Acc. No. R23544 for yg34c12.rl Soares infant brain 1NIBHomo sapienscDNA clone Image:34465 5′, mRNA sequence Apr. 23, 1995.
Database EMBL Acc. No. AI614037 for vg32f09.y1 Soares—mammary—gland—NbMMGMus musculuscDNA clone Image:863081 5′ similar to TR:O75144 O75144 KIAA0653 Protein; mRNA sequence Apr. 26, 1999.
GenBank Acc. No. Y08823 forG. gallusmRNA for CD80-like protein precursor, Sep. 30, 1997.
GenBank Acc. No. U67065 forMus musculusbutyrophilin (BTN) gene, promoter region and complete cds, Mar. 29, 1997.
GenBank Acc. No. AC006508 forMus musculusYp BAC GSMB-187H15 (Genome Systems Mouse BAC Library) complete sequence, Feb. 15, 2000.
GenBank Acc. No. AC005818 forMus musculuschromosome 10 clone rp21-411d9 strain 129S6/SvEvTac, complete sequence, Aug. 29, 2000.
GenBank Acc. No. AF115517 forMus musculussurvivin40, survivin121 and survivin140 genes, alternative splice products, complete cds, Apr. 20, 1999.
GenBank Acc. No. Z18892 forMus musculusdesmin gene, Jun. 21, 1999.
GenBank Acc. No. AF087694 forMus musculusveli 2 mRNA, complete cds, Nov. 20, 1998.
GenBank Acc. No. AF173082 forMus musculusLIN-7 homolog 2 (MALS-2) mRNA, complete cds, Aug. 11, 1999.
GenBank Acc. No. BAA31628 for KIAA0653 protein [Homo sapiens], Feb. 6, 1999.
Hattori et al., “The DNA sequence of human chromosome 21,” Nature 18;405(6784):311-9 (2000).
Henry et al., “Cloning, structural analysis, and mapping of the B30 and B7 multigenic families to the major histocompatibility complex (MHC) and other chromosomal regions,” Immunogenetics, 46(5):383-95 (1997).
Hutlof et al., “ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28,” Nature, 21:397(6716):263-6 (1999).
Ishikawa et al., “Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro,” DNA Res. 5(3):169-176 (1998).
Jo et al., “Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex,” J. Neurosci. 19(11):4189-4199 (1999).
Li et al., “Regulation of the mouse desmin gene: transactivated by MyoD, myogenin, MRF4 and Myf5,” Nucleic Acids Res. 21(2):335-343 (1993).
Ling et al., “Embryonic stem cells and embryoid bodies express lymphocyte costimulatory molecules,” Exp. Cell Res., 241(1):55-65 (1998).
Ling et al., “Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor,” J. Immunol., 164(4):1653-7 (2000).
Ling et al., Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules, J. Immunol., 166(12):7300-8 (2001).
Metzler et al., “Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28,” Nature Structural Biol., 4:527-531 (1997).
Ogg et al., “Structural organization and mammary-specific expression of the butyrophilin gene,” Mamm. Genome 7(12):900-905 (1996).
Siffert et al., “Association of a human G-protein beta3 subunit variant with hypertension,” Nat. Genet., 18(1):45-8 (1998).
Skolnick et al., “From genes to protein structure and function: novel applications of computational approaches in the genomic era,” Trends in Biotech, 18(1):34-39 (2000).
Wang et al., “Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS,” Blood, 96(8):2808-2813 (2000).
Yoshinaga et al., “T-cell co-stimulation through B7RP-1 and ICOS,” Nature, 402(6763):827-32 (1999).
Zuberek et al., “Therapeutic efficacy of icos/GL50 (B7h) T cell costimulatory pathway in tumor models,” Blood 96(11):239A.
NCBI Accession No. 075144, Nonstructural protein NS1—Influenza A Virus, Jul. 16, 1999.
Greenwald et al., “The B7 Family Revisited,” Annu. Rev. Immunol., 23:515-48 (2005).

Affiliated with

Also associated with

Rating

Anti-GL50 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-GL50 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-GL50 antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4103831